PRILIGY Film-coated tablet Ref.[8388] Active ingredients: Dapoxetine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2021  Publisher: A. Menarini Farmaceutica Internazionale SRL, Menarini House, Mercury Park, Wycombe Lane, Wooburn Green, Buckinghamshire, HP10 0HH

Product name and form

Priligy 30 mg film-coated tablets.

Priligy 60 mg film-coated tablets.

Pharmaceutical Form

Film-coated tablet.

The 30 mg film-coated tablets are light grey, round, convex, approximately 6.5 mm in diameter and debossed with “30” inside a triangle on one side.

The 60 mg film-coated tablets are grey, round, convex, approximately 8 mm in diameter and debossed with “60” inside a triangle on one side.

Qualitative and quantitative composition

Each film-coated tablet contains dapoxetine hydrochloride equivalent to 30 mg or 60 mg dapoxetine.

Excipient with known effect: Lactose. Each 30 mg tablet contains 45.88 mg of lactose. Each 60 mg tablet contains 91.75 mg of lactose.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Dapoxetine

Dapoxetine is a potent selective serotonin reuptake inhibitor (SSRI). The mechanism of action of dapoxetine in premature ejaculation is presumed to be linked to the inhibition of neuronal reuptake of serotonin and the subsequent potentiation of the neurotransmitter’s action at pre- and postsynaptic receptors.

List of Excipients

Tablet core:

Lactose monohydrate
Microcrystalline cellulose
Croscarmellose sodium
Colloidal anhydrous silica
Magnesium stearate

Tablet coating:

Lactose monohydrate
Hypromellose
Titanium dioxide (E171)
Triacetin
Iron Oxide Black (E172)
Iron Oxide Yellow (E172)

Pack sizes and marketing

Child-resistant PVC-PE-PVDC/Alu blister in compliance multi-fold packages of 1, 2, 3 and 6 film-coated tablets. Not all pack sizes may be marketed.

Marketing authorization holder

A. Menarini Farmaceutica Internazionale SRL, Menarini House, Mercury Park, Wycombe Lane, Wooburn Green, Buckinghamshire, HP10 0HH

Marketing authorization dates and numbers

PL 41549/0001
PL 41549/0002

Date of first authorisation: 17 December 2008
Date of last renewal: 17 December 2013

Drugs

Drug Countries
PRILIGY Austria, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.